Cancer Pharmacogenomics: SNPs, Chips, and the Individual Patient (Q35553873)

8 August 2017

1 reference

title

Cancer pharmacogenomics: SNPs, chips, and the individual patient (English)

1 reference

8 August 2017

Cancer Pharmacogenomics: SNPs, Chips, and the Individual Patient (English)

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533451

19 March 2024

DNA microarray

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533451

single-nucleotide polymorphism

19 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533451

19 March 2024

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

author name string

Jinsheng Yu

2

1 reference

8 August 2017

Howard L. McLeod

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14533451

19 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14533451

19 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.1081/CNV-120022384

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

1 reference

8 August 2017

21

1 reference

8 August 2017

4

1 reference

8 August 2017

630-640

1 reference

Pharmacogenomics: translating functional genomics into rational therapeutics

8 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Pharmacogenomics: unlocking the human genome for better drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Exploring the new world of the genome with DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Comparative genomic hybridization and chromosomal instability in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Pharmacogenetics of cancer therapy: getting personal

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Gene-Expression Profiles in Hereditary Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Thiopurine methyltransferase alleles in British and Ghanaian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Drug target validation and identification of secondary drug target effects using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Polymorphism of the thiopurine S-methyltransferase gene in African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Etoposide and antimetabolite pharmacology in patients who develop secondary acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

The pharmacogenetics of codeine hypoalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

The hypoalgesic effect of tramadol in relation to CYP2D6*

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120022384

Prognostic significance of reverse transcriptase polymerase chain reaction for prostate-specific antigen in men with hormone-refractory prostate cancer

21 January 2018

11

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year

19 March 2024

12

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

16

58

5042

Rooney P.H.

1998

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

44

60

6921

Ando Y.

2000

1 reference

https://api.crossref.org/works/10.1081/CNV-120022384

19 March 2024

Identifiers

1 reference

8 August 2017

1 reference